缩写名/全名 |
MULT SCLER J
Multiple Sclerosis Journal |
||||||||||||
ISSN号 | 1352-4585 | ||||||||||||
研究方向 | CLINICAL NEUROLOGY-NEUROSCIENCES | ||||||||||||
影响因子 | 2015:4.671, 2016:4.84, 2017:5.28, 2018:5.649, 2019:5.412, | ||||||||||||
出版国家 | ENGLAND | ||||||||||||
出版周期 | |||||||||||||
年文章数 | 193 | ||||||||||||
出版年份 | 0 | ||||||||||||
是否OA | No | ||||||||||||
审稿周期(仅供参考) | |||||||||||||
录用比例 | |||||||||||||
投稿链接 | https://uk.sagepub.com/en-gb/asi/multiple-sclerosis-journal/journal201820#submission-guidelines | ||||||||||||
投稿官网 | https://uk.sagepub.com/en-gb/asi/multiple-sclerosis-journal/journal201820 | ||||||||||||
h-index | |||||||||||||
CiteScore |
|
||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1352-4585%5BISSN%5D | ||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Amiloride does not protect retinal nerve fibre layer thickness in optic neuritis in a phase 2 randomised controlled trial. Author: McKee JB1, Cottriall CL2, Elston J2, Epps S3, Evangelou N4, Gerry S5, Kennard C6, Kong Y7, Koelewyn A8, Kueker W9, Leite MI8, Palace J8, Craner M8. Journal: Mult Scler. 2019 Feb;25(2):246-255. doi: 10.1177/1352458517742979. Epub 2017 Nov 27. PubMed DOI |
2. | Enhancing natural killer cells is beneficial in multiple sclerosis - No. Author: Liu Q1, Shi FD2. Journal: Mult Scler. 2019 Apr;25(4):512-513. doi: 10.1177/1352458518799591. Epub 2018 Nov 13. PubMed DOI |
3. | Characteristics of lesional and extra-lesional cortical grey matter in relapsing-remitting and secondary progressive multiple sclerosis: A magnetisation transfer and diffusion tensor imaging study. Author: Yaldizli Ö, Pardini M, Sethi V, Muhlert N, Liu Z, Tozer DJ, Samson RS, Wheeler-Kingshott CA, Yousry TA, Miller DH, Chard DT. Journal: Mult Scler. 2016 Feb;22(2):150-9. doi: 10.1177/1352458515586085. Epub 2015 May 26. PubMed |
4. | Impaired retinal microcirculation in multiple sclerosis. Author: Jiang H, Delgado S, Tan J, Liu C, Rammohan KW, DeBuc DC, Lam BL, Feuer WJ, Wang J. Journal: Mult Scler. 2016 Feb 22. pii: 1352458516631035. [Epub ahead of print] PubMed |
5. | Integrating genome-wide association studies and gene expression data highlights dysregulated multiple sclerosis risk pathways. Author: Liu G, Zhang F, Jiang Y, Hu Y, Gong Z, Liu S, Chen X, Jiang Q, Hao J. Journal: Mult Scler. 2016 May 19. pii: 1352458516649038. [Epub ahead of print] PubMed |
6. | A tract-based diffusion study of cerebral white matter in neuromyelitis optica reveals widespread pathological alterations. Author: Liu Y, Duan Y, He Y, Yu C, Wang J, Huang J, Ye J, Butzkueven H, Li K, Shu N. Journal: Mult Scler. 2012 Jul;18(7):1013-21. doi: 10.1177/1352458511431731. Epub 2011 Dec 19. PubMed |
7. | Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis. Author: Quan C, Yu H, Qiao J, Xiao B, Zhao G, Wu Z, Li Z, Lu C. Journal: Mult Scler. 2013 Mar;19(3):289-98. doi: 10.1177/1352458512454771. Epub 2012 Aug 3. PubMed |
8. | Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica. Author: Wang H, Wang K, Wang C, Zhong X, Qiu W, Hu X. Journal: Mult Scler. 2012 Sep 25. [Epub ahead of print] PubMed |
9. | Meningoencephalitis as an initial manifestation of neuromyelitis optica spectrum disorder. Author: Wang JY, Wang K, Chen XW, Wang JW, Zhang K, Xu MW, Luo BY. Journal: Mult Scler. 2013 Apr;19(5):639-43. doi: 10.1177/1352458512459785. Epub 2012 Oct 15. PubMed |
|
|